Klinikum der Universität München (LMU Klinikum)

Adjuvant radiotherapy for breast cancer. Which patients benefit from DIBH (deep inspiration breath-hold)? Adjuvante Strahlentherapie beim Mammakarzinom (2021) Schönecker S, Schäfer A, Pazos M, Corradini S Journal article Noncanonical effector functions of the T-memory-like T-PLL cell are shaped by cooperative TCL1A and TCR signaling (2020) Oberbeck S, Schrader A, Warner K, Jungherz D, Crispatzu G, Von Jan J, Chmielewski M, et al. Journal article Alveolar regeneration through a Krt8+ transitional stem cell state that persists in human lung fibrosis (2020) Strunz M, Simon LM, Ansari M, Kathiriya JJ, Angelidis I, Mayr CH, Tsidiridis G, et al. Journal article Influence of Natural Killer Cells and Natural Killer T Cells on Periodontal Disease: A Systematic Review of the Current Literature (2020) Seidel A, Seidel CL, Weider M, Junker R, Gölz L, Schmetzer H Journal article, Review article Pelvic Lymphadenectomy in Vulvar Cancer – Does it make sense? (2020) Woelber L, Bommert M, Prieske K, Fischer I, Zu Eulenburg C, Vettorazzi E, Harter P, et al. Journal article Vocal fold oscillation pattern changes related to loudness in patients with vocal fold mass lesions (2020) Echternach M, Döllinger M, Köberlein M, Kuranova L, Gellrich D, Kainz MA Journal article Gemcitabine as adjuvant chemotherapy in patients with high-risk early breast cancer—results from the randomized phase III SUCCESS-A trial (2020) de Gregorio A, Häberle L, Fasching P, Müller V, Schrader I, Lorenz R, Forstbauer H, et al. Journal article Correction to: Recent advances in Surface Guided Radiation Therapy (Radiation Oncology, (2020), 15, 1, (187), 10.1186/s13014-020-01629-w) (2020) Freislederer P, Kügele M, Öllers M, Swinnen A, Sauer TO, Bert C, Giantsoudi D, et al. Journal article, Erratum Severe neurological outcomes after very early bilateral nephrectomies in patients with autosomal recessive polycystic kidney disease (ARPKD) (2020) Burgmaier K, Ariceta G, Bald M, Buescher AK, Burgmaier M, Erger F, Gessner M, et al. Journal article Interleukin-6 trans-signaling is a candidate mechanism to drive progression of human DCCs during clinical latency (2020) Werner-Klein M, Grujovic A, Irlbeck C, Obradović M, Hoffmann M, Koerkel-Qu H, Lu X, et al. Journal article